Daiichi Sankyo, Inc. Turns to Profit, Appoints New CEO, Joji Nakayama

May 12, 2010 |

1 min read

Bloomberg -- Daiichi Sankyo Co., Japan’s third- largest drugmaker, posted a full-year profit after a one-time charge in the previous period related to its Indian unit Ranbaxy Laboratories Ltd.

People

Daiichi Sankyo

MORE ON THIS TOPIC

A brain hovers over a hand against a yellow-striped background

Neuroscience

Novartis drops $125M for Sironax’s tech to cross blood-brain barrier

September 17, 2026

·

2 min read

·

Tristan Manalac

Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out

Immunology and inflammation

Roche bets up to $1B to advance next-gen bispecifics with Dualitas

September 17, 2026

·

1 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Sionna says good-bye to 46% of staffers, including exec

September 16, 2026

·

93 min read

·

BioSpace Editorial Staff

Businessman holding a net bag chasing banknotes in the air, business concept illustration

Funding

Sling catches $123M series C for thyroid eye disease pill

September 16, 2026

·

2 min read

·

Tristan Manalac